Aplastic anaemia is a serious and potentially life-threatening blood disorder in which the bone marrow fails to produce enough blood cells. Bone marrow is responsible for generating red blood cells, white blood cells, and platelets—each playing a critical role in maintaining the body’s health. Red blood cells carry oxygen throughout the body, white blood cells help fight infections, and platelets assist in blood clotting.
When the levels of all three blood cell types drop significantly, the condition is known as pancytopenia. Unlike common forms of anaemia such as iron deficiency anaemia—which can often be treated with supplements and improved nutrition—aplastic anaemia requires complex medical care. In many cases, patients need specialized treatments such as immunosuppressive therapy or stem cell transplantation to restore healthy bone marrow function.
The Burden of Aplastic Anaemia in India
India reports thousands of aplastic anaemia cases every year. Clinical studies conducted in the country show that a significant proportion of patients who present with pancytopenia are eventually diagnosed with this condition. Medical reviews also suggest that aplastic anaemia represents a considerable share of bone marrow failure cases in India.
Another notable observation is that Indian patients often develop the disease at a younger age compared to patients in Western countries. While the exact cause of aplastic anaemia is often unknown, several factors have been linked to the disorder. These include autoimmune conditions in which the body’s immune system mistakenly attacks bone marrow cells, as well as exposure to certain chemicals, toxins, medications, and radiation.
The combination of these factors makes aplastic anaemia an important health concern in the country, highlighting the need for increased awareness and improved treatment access.
Stem Cell Transplant: A Potential Life-Saving Treatment
For patients with severe aplastic anaemia, a hematopoietic stem cell transplant—commonly referred to as a bone marrow or blood stem cell transplant—is often considered the most effective treatment option. The procedure involves replacing damaged bone marrow with healthy stem cells from a compatible donor.
Healthy stem cells have the ability to regenerate and produce new blood cells, restoring the body’s ability to maintain normal blood cell levels. When successful, this treatment can offer a long-term cure for many patients.
However, the success of a stem cell transplant depends heavily on finding a suitable donor whose genetic markers closely match those of the patient.
Why Finding a Compatible Donor Is Difficult
Compatibility between a donor and a patient is determined through specific genetic markers known as human leukocyte antigens (HLA). These markers help the immune system distinguish between the body’s own cells and foreign cells. For a transplant to work safely, the donor’s HLA markers must closely match those of the patient.
Because these markers are inherited genetically, the best chance of finding a match usually lies within the patient’s family, especially among siblings. Even then, only about one in four patients is likely to find a suitable donor within their immediate family.
For the remaining majority of patients, the search extends to unrelated donors through national or international stem cell registries. Unfortunately, this is where one of India’s biggest challenges emerges.
India’s Limited Stem Cell Donor Registry
India faces a significant shortage of registered blood stem cell donors. Currently, only about 0.09% of the country’s eligible population is registered in stem cell donor databases. This extremely small donor pool dramatically reduces the chances of patients finding compatible matches.
In contrast, several developed countries have much larger donor registries, which increases the likelihood of locating unrelated matches. The limited participation in India means that many patients are forced to search international registries, which can be expensive and time-consuming.
For families already dealing with the emotional and financial burden of a life-threatening illness, the difficulty of finding a donor can make treatment even more challenging.
Genetic Diversity Adds to the Challenge
India’s vast population is genetically diverse, with multiple ethnic groups and regional genetic variations. This diversity means that patients are more likely to find compatible matches among donors who share similar ethnic backgrounds.
However, because so few people in India are registered as stem cell donors, the chances of finding a match within the country remain low. As a result, many patients struggle to identify suitable donors in time for transplantation.
Lack of Awareness About Stem Cell Donation
One of the major reasons for the limited donor registry in India is a lack of awareness about stem cell donation. Many individuals are unfamiliar with how the donation process works or believe that it involves complicated or risky procedures.
In reality, donating blood stem cells is generally safe. In most cases, stem cells are collected from the donor’s bloodstream through a process similar to blood donation. The body naturally replaces the donated stem cells within a short period.
Despite this, misconceptions and limited public education continue to discourage people from registering as donors.
The Need for Greater Public Participation
Increasing the number of registered stem cell donors is crucial for improving treatment outcomes for patients with aplastic anaemia and other serious blood disorders such as leukemia and lymphoma.
Public awareness campaigns, educational programs, and community outreach initiatives can play a significant role in encouraging more individuals to join donor registries. Young adults are particularly encouraged to register, as younger donors often provide better transplant outcomes.
Healthcare institutions, government bodies, and non-profit organizations have begun taking steps to expand India’s donor registry. However, the progress needs to accelerate to meet the growing demand.
A Lifeline for Thousands of Patients
For individuals diagnosed with severe aplastic anaemia, access to a compatible stem cell donor can mean the difference between life and death. Without timely treatment, patients face serious complications such as infections and uncontrolled bleeding due to low blood cell counts.
Expanding India’s stem cell donor pool could significantly improve survival rates and provide new hope for thousands of patients every year. Greater awareness, increased participation in donor registries, and continued medical advancements are essential to overcoming the current challenges and ensuring that more patients can receive the life-saving treatment they urgently need.
launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell launcheell
